RPCEC00000353尚未招募2 期
asal and Sublingual Application of the CIGB 2020 Therapeutic Vaccine in patients with SARS-CoV-2 infection. Randomized controlled clinical trial (COVID-19) - AVATAR-2020
Center for Genetic Engineering and Biotechnology (CIGB), in Havana0 个研究点目标入组 354 人开始时间: 2021年3月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 354
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Treatment
入排标准
- 年龄范围
- 35 years 至 one （—）
- 性别
- All
入选标准
- •1) Asymptomatic or mild symptomatic Sars Cov 2 PCR-positive patients (Clinical Categories 1 and 2 of the NIH classification).
- •2) Age over 35 years.
- •3) Voluntariness of the patient by signing the informed consent.
排除标准
- •1) Pregnancy or lactation at the time of inclusion in the study.
- •2) Patients included in another clinical trial.
- •3) Diseases that compromise the patient's state of consciousness or their ability to give informed consent or collaborate in the trial.
- •4) Moderate, severe or critical stage (3, 4 and 5) of the NIH classification.
- •5) Anatomical, functional or psychological conditions that prevent the nasal or sublingual application of the Produ
研究者
相似试验
尚未招募
不适用
CIGB2020- ARI elderly contactsAcute Respiratory Infection (ARI)COVID-19SARS-CoV2Respiratory Tract InfectionsRespiratory Tract DiseasesCoronavirus InfectionsSARS VirusCoronaviridae InfectionsNidovirales InfectionsBetacoronavirusDisease PreventionImmunosenescenceRPCEC00000356Center for Genetic Engineering and Biotechnology (CIGB)1,440
招募中
1 期
CIGB 2020 in contacts and SARS-CoV-2 infection suspectsContacts and SARS-CoV-2 infection suspectssuspected of SARS-CoV-2 infectionCoronaviridae InfectionsSARS VirusCoronavirus InfectionsBetacoronavirusRPCEC00000306Center for Genetic Engineering and Biotechnology (CIGB), in Havana80
尚未招募
2 期
CERVICONC-II-300 studyCervical cancer in stages IB2 and II.Uterine Cervical NeoplasmsUterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesRPCEC00000285Center for Genetic Engineering and Biotechnology (CIGB), in Havana144
已完成
2 期
InCarbacel-IISkin basal cell carcinoma (BCC)Carcinoma, Basal CellSkin NeoplasmsNeoplasms, Basal CellNeoplasms, Glandular and EpithelialCarcinomaSkin DiseasesRPCEC00000066Center for Genetic Engineering and Biotechnology (CIGB)60
招募中
1 期
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency.Infection with hepatitis C virus.RPCEC00000098Centro de Ingeniería Genética y Biotecnología (CIGB).60